In a shocking development for the Atlanta Braves, outfielder Jurickson Profar has been handed a 162-game suspension after testing positive for a performance-enhancing substance. The ban, which takes effect Friday, would effectively sideline Profar for the entirety of the 2026 season, including any postseason appearances, and would result in a significant loss of salary if upheld. According to Ken Rosenthal of The Athletic, the Players Association is gearing up to contest the suspension, planning to file a grievance that could delay the enforcement of the ban as it navigates through MLB’s Joint Drug Prevention and Treatment Program.
This unexpected turn of events raises immediate questions about the Braves’ outfield depth as they prepare for the upcoming season. Profar was expected to play a pivotal role in the lineup, and his absence forces the team to reassess their roster strategy, prompting them to explore both internal solutions and potential external acquisitions to fill the void left by the suspended player.
In other MLB news, Milwaukee Brewers starter Quinn Priester is currently lagging behind in his preparation for the season due to wrist soreness, raising concerns about his availability for Opening Day. Additionally, the league has seen another outfielder, Johan Rojas of the Philadelphia Phillies, receive an 80-game suspension following a failed performance-enhancing drug test. These developments illustrate the ongoing challenges teams face as they manage player health and compliance with league policies.
Note: This recap is an independently written summary based on publicly available reporting.
PHI
NYM
KC
PIT
CHC
CIN
OAK
CLE
BOS
TB
DET
CHW
ATL
HOU
WSH
STL
TOR
TEX
SEA
COL
MIN
LAA
NYY
ARI
SF
LAD
MIA
SD
MIL
BAL
NYI
NJ
SJ
ANA
WSH
BOS
NSH
TB
UTA
COL
CAR
FLA
SEA
CGY
CAR
ATL
MIN
CHI
PHI
TEN
PIT
NE
GB
NYJ
CLE
TB
NO
BAL
CIN
HOU
JAX
DEN
LV
LAC
WAS
DAL
SEA
ARI
MIA
SF
IND
KC
PHI
DET
CBJ
BUF
PIT
NYR
OTT
MTL
WPG
MIN
CHI
STL
DAL
NYG
LA